Search research articles
Contact Us
Filters
Showing results (1-10 of 133) with videos related to
Page
of 14
Sort By:
Expert Review of Anticancer Therapy
|
October 1, 2021
Evaluating efficacy and safety of loncastuximab tesirine injection for the treatment of adult patients with relapsed or refractory large B-cell lymphoma
Nausheen Ahmed, Mehdi Hamadani
Transplantation and Cellular Therapy
|
January 18, 2026
G-CSF Timing After CAR-T: Early, Late - or Just Irrelevant?
Nausheen Ahmed, Zahra Mahmoudjafari
Blood
|
June 27, 2024
Axi-cel outcomes among non-Hispanic Black patients
William Wesson, Nausheen Ahmed
Blood Advances
|
May 28, 2024
Race and insurance: real-world insights on CAR-T outcomes
Nausheen Ahmed, Natalie S Grover
European Journal of Cancer (Oxford, England : 1990)
|
December 6, 2025
Response to letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
Nikhil Vojjala, Prakash Neupane, Nausheen Ahmed
Transplantation and Cellular Therapy
|
January 9, 2026
From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs
Zahra Mahmoudjafari, Joseph McGuirk, Nausheen Ahmed
Connecticut Medicine
|
January 6, 2012
Bone marrow metastasis as first recurrence of gastric cancer: a case report
Nausheen Ahmed, Xuemei Li, Joerg Rathmann
Transplantation and Cellular Therapy
|
August 13, 2025
From Risk to Reach: How REMS Remediation Will Shape CAR-T Access
Muhammad Bilal Abid, Noufil Adnan, Nausheen Ahmed
Transplantation and Cellular Therapy
|
April 24, 2023
Dawn of Hope for Improved Access to BCMA Therapy: Chimeric Antigen Receptor T Cell and Bispecific Products
Nausheen Ahmed, William Wesson, Al-Ola Abdallah
Expert Opinion on Biological Therapy
|
May 8, 2012
Immune alterations and emerging immunotherapeutic approaches in lung cancer
Constantin A Dasanu, Nishant Sethi, Nausheen Ahmed
Page
of 14
Search research articles
Search
Showing results (1-10 of 133) with videos related to
Sort By:
Page
of 14
Expert Review of Anticancer Therapy
|
October 1, 2021
Evaluating efficacy and safety of loncastuximab tesirine injection for the treatment of adult patients with relapsed or refractory large B-cell lymphoma
Nausheen Ahmed, Mehdi Hamadani
Transplantation and Cellular Therapy
|
January 18, 2026
G-CSF Timing After CAR-T: Early, Late - or Just Irrelevant?
Nausheen Ahmed, Zahra Mahmoudjafari
Blood
|
June 27, 2024
Axi-cel outcomes among non-Hispanic Black patients
William Wesson, Nausheen Ahmed
Blood Advances
|
May 28, 2024
Race and insurance: real-world insights on CAR-T outcomes
Nausheen Ahmed, Natalie S Grover
European Journal of Cancer (Oxford, England : 1990)
|
December 6, 2025
Response to letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
Nikhil Vojjala, Prakash Neupane, Nausheen Ahmed
Transplantation and Cellular Therapy
|
January 9, 2026
From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs
Zahra Mahmoudjafari, Joseph McGuirk, Nausheen Ahmed
Connecticut Medicine
|
January 6, 2012
Bone marrow metastasis as first recurrence of gastric cancer: a case report
Nausheen Ahmed, Xuemei Li, Joerg Rathmann
Transplantation and Cellular Therapy
|
August 13, 2025
From Risk to Reach: How REMS Remediation Will Shape CAR-T Access
Muhammad Bilal Abid, Noufil Adnan, Nausheen Ahmed
Transplantation and Cellular Therapy
|
April 24, 2023
Dawn of Hope for Improved Access to BCMA Therapy: Chimeric Antigen Receptor T Cell and Bispecific Products
Nausheen Ahmed, William Wesson, Al-Ola Abdallah
Expert Opinion on Biological Therapy
|
May 8, 2012
Immune alterations and emerging immunotherapeutic approaches in lung cancer
Constantin A Dasanu, Nishant Sethi, Nausheen Ahmed
Page
of 14